Ocugen, Inc. (OCGN)
0.7027
-0.04
(-5.58%)
USD |
NASDAQ |
Oct 30, 16:00
0.7168
+0.01
(+2.01%)
Pre-Market: 20:00
Ocugen 30-Day Average Daily Volume : 6.823M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 6.823M |
| October 29, 2026 | 7.134M |
| October 28, 2026 | 7.080M |
| October 27, 2026 | 7.076M |
| October 26, 2026 | 7.208M |
| October 23, 2026 | 7.153M |
| October 22, 2026 | 7.083M |
| October 21, 2026 | 7.601M |
| October 20, 2026 | 8.765M |
| October 19, 2026 | 8.637M |
| October 16, 2026 | 8.607M |
| October 15, 2026 | 8.516M |
| October 14, 2026 | 8.461M |
| October 13, 2026 | 8.216M |
| October 12, 2026 | 8.142M |
| October 09, 2026 | 8.136M |
| October 08, 2026 | 7.788M |
| October 07, 2026 | 7.455M |
| October 06, 2026 | 7.434M |
| October 05, 2026 | 7.354M |
| October 02, 2026 | 7.252M |
| October 01, 2026 | 7.269M |
| September 30, 2026 | 7.330M |
| September 29, 2026 | 7.170M |
| September 28, 2026 | 7.001M |
| Date | Value |
|---|---|
| September 25, 2026 | 6.939M |
| September 24, 2026 | 6.780M |
| September 23, 2026 | 6.698M |
| September 22, 2026 | 6.375M |
| September 21, 2026 | 6.312M |
| September 18, 2026 | 6.324M |
| September 17, 2026 | 6.018M |
| September 16, 2026 | 6.097M |
| September 15, 2026 | 6.013M |
| September 14, 2026 | 5.709M |
| September 11, 2026 | 5.625M |
| September 10, 2026 | 5.526M |
| September 09, 2026 | 5.017M |
| September 08, 2026 | 3.871M |
| September 04, 2026 | 3.945M |
| September 03, 2026 | 3.964M |
| September 02, 2026 | 3.993M |
| September 01, 2026 | 3.960M |
| August 31, 2026 | 4.144M |
| August 28, 2026 | 4.143M |
| August 27, 2026 | 4.167M |
| August 26, 2026 | 4.237M |
| August 25, 2026 | 4.289M |
| August 24, 2026 | 4.302M |
| August 21, 2026 | 4.390M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.037M |
| Anika Therapeutics, Inc. | 102338.5 |
| Gilead Sciences, Inc. | 5.928M |
| MannKind Corp. | 4.638M |
| Nektar Therapeutics | 1.518M |